<html><head><style>body{font-family:"Times New Roman", Times, serif}.Bold{font-weight:bolder}.font-size\:9px{font-size:9px}.font-size\:11px{font-size:11px}.Heading1,.Heading.\31 {font-size:32px}.Heading2,.Heading.\32,.Subpart{font-size:24px}.Heading3,.Heading.\33 {font-size:20.8px}.Heading4,.Heading.\34 {font-size:16px}ol,li,ul{list-style:none}.SmallCaps{font-variant:small-caps}.data-about{padding-top:10px}p{margin:0;padding:7px}br{display:none}.rangeWrapperHighlight{background-color:#add2ff}.caseWrapperHighlight{background-color:#6fd33d}.whyWrapperHighlight{background-color:#fc5151}.revWrapperHighlight{background-color:#add2ff;padding:1px}.Ctr,.Subpart{text-align:center}img.Right{float:right}.Right{text-align:right}.List1{margin-left:0px;text-indent:0}.List2{margin-left:0.25in;text-indent:0}.List3{margin-left:0.5in;text-indent:0}.List4{margin-left:0.75in;text-indent:0}.List5{margin-left:1in;text-indent:0}.List6{margin-left:1.25in;text-indent:0}.List7{margin-left:1.5in;text-indent:0}.List8{margin-left:1.75in;text-indent:0}.List9{margin-left:2in;text-indent:0}.italic{font-style:italic}.regnavigation{display:none}.Yellow{background-color:yellow}.LightBlue{background-color:#4863a0}.AquaGreen{background-color:#03bb85}.section{background-color:#eeeeee;border:1px solid #cccccc;padding:5px 10px}
</style><head><div xmlns:TCE="http://www.TCE.com" xmlns:TCEext="http://www.TCE.com/xslt-extensions" xmlns:ditaarch="http://dita.oasis-open.org/architecture/2005/" xmlns:fn="http://www.w3.org/2005/xpath-functions" xmlns:xs="http://www.w3.org/2001/XMLSchema" class="l3 AFFARS"><div TCE:source="dita" TCE:Parent=""><p>**ID__AFFARS_MP5325_7003_3_1__ID** </p><div TCE:source="concept" TCE:Parent="dita" TCE:id="AFFARS_MP5325_7003_3_1" class="- topic/topic concept/concept  1.3 (topic concept)                            (topic abbrev-d)                            a(props deliveryTarget)                            (topic equation-d)                            (topic hazard-d)                            (topic hi-d)                            (topic indexing-d)                            (topic markup-d)                            (topic mathml-d)                            (topic pr-d)                            (topic relmgmt-d)                            (topic sw-d)                            (topic svg-d)                            (topic ui-d)                            (topic ut-d)                            (topic markup-d xml-d)    AFFARS_MP5325_7003_3_1 en-US "><h3 TCE:Parent="concept" TCE:outputclass="Heading 2" class="- topic/title  Heading 2 "><span TCE:source="ph" TCE:Parent="title" TCE:props="autonumber" class="- topic/ph  autonumber ">1.</span> Domestic Non-Availability Determinations (DNAD) Under DFARS 225.7003</h3><div TCE:source="conbody" TCE:Parent="concept"><p TCE:source="p" TCE:Parent="conbody" TCE:id="p__Toc38365662" TCE:outputclass="Normal" class="- topic/p  p__Toc38365662 Normal ">Follow these mandatory procedures (MP) when requesting approval to purchase restricted specialty metals under DFARS 225.7003. The requirement to comply with these statutory and regulatory restrictions applies to procurements in excess of the simplified acquisition threshold. This MP provides guidance for drafting DNAD and Commercial Derivative Military Article (CDMA) Determination and Finding (D&amp;F) documents. The DNAD or CDMA D&amp;Fs should be tailored to the particular acquisition. In some cases, the contracting officer may not be able to obtain all of the data specified in the templates referenced below; however, the contracting officer should make every effort to do so.</p></div></div></div></div></html>